Cantor Fitzgerald Reiterates Overweight Rating on Oracle (March 11)

Analyst: Thomas Blakey 1 min read Reproduced verbatim
Rating
Overweight
Unchanged
Target
$229
Unchanged
Outcome
Reached
on June 1, 2026

Cantor’s latest target on Oracle is now $284 (Oct 22, 2026); the median of 23 firms is $240. Cantor has reached 78% of its year-old targets (59 scored).

Cantor and Oracle logos

What the analyst said

Cantor Fitzgerald analyst Thomas Blakey reiterated an Overweight rating and $229.00 price target on Oracle (NYSE: ORCL).

“Oracle delivered strong AI-driven momentum in F3Q26, with robust growth in AI infrastructure (+243%) and multicloud DBaaS revenue (+531%) alongside solid SaaS performance (+13% reported, +11% cc), which was explained as being possibly immune to the SaaS-pocalypse.

Management highlighted halo effects from AI infrastructure and sovereign cloud, driving broader enterprise engagement with its end-to-end solution set, better positioning the company versus SaaS-only app providers. Given its diverse product set, Oracle appears to be taking a more disruptive approach to deploying AI agents across its applications and application suites, as well as aggressively utilizing coding tools internally to use smaller, more agile teams to deliver SaaS enhancements more quickly to customers, leveraging its data gravity associated with its AI platform and core DB services.

AI infrastructure margins exceeded expectations at 32%, supporting confidence in long-term profitability as scale improves in this important business line and core IaaS/OCI (excl CDBS) is now approaching 25% of total revenue and growing ~100% y/y, by our estimation.

We see Oracle’s vertically integrated stack (OCI, AI data platform, and applications) positioning the company to capture outsized AI-driven demand across its ecosystem of apps, DB, and infrastructure services, and driving sustainable profitable growth supporting our OW rating and our $229 PT.”

Cite this note: Price Target, "Cantor Fitzgerald Reiterates Overweight Rating on Oracle (March 11)," March 11, 2026. https://price-target.com/2026/03/11/170200/
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $101. The 23 analysts who set a target in the last 3 months range from $155 to $400, with a median of $240. This $229 target is 5% below the median.

Since the note ORCL has moved −32% (from $149). 12-month window: day 255 of 365, closes on March 11, 2027.

Track record

This call✓ Target reached on June 1, 2026, 3 months after the note.

Firm track recordCantor: 78% of its 59 targets at least a year old were reached within 12 months (#15 of 29 firms). Accuracy ranking →

Earnings reactionOne of 16 notes after Oracle’s Mar 10 results: 4 raised · 2 cut · 8 kept. See every call →

Cantor on Oracle

Cantor price targets on Oracle

4 calls from March 11, 2026 to October 22, 2026. The target went from $229 to $284 (+24%). The rating stayed Buy.

Cantor targetORCL share price
  1. October 22, 2026Kept the $284 targetBuy$284
  2. September 11, 2026Kept the $284 targetBuy$284
  3. June 11, 2026Target raised from $229 (+24%)Buy$284
  4. March 11, 2026 This noteEarliest call shownBuy$229
Share Reddit StockTwits
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.